HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $7,000 | -78.8% | 170 | -77.1% | 0.00% | -100.0% |
Q2 2022 | $33,000 | +266.7% | 741 | +223.6% | 0.00% | – |
Q1 2022 | $9,000 | +125.0% | 229 | +112.0% | 0.00% | – |
Q3 2021 | $4,000 | -50.0% | 108 | -35.3% | 0.00% | – |
Q2 2021 | $8,000 | +60.0% | 167 | +47.8% | 0.00% | – |
Q1 2021 | $5,000 | +400.0% | 113 | +653.3% | 0.00% | – |
Q4 2020 | $1,000 | -83.3% | 15 | -93.0% | 0.00% | – |
Q3 2020 | $6,000 | 0.0% | 214 | 0.0% | 0.00% | – |
Q2 2020 | $6,000 | – | 214 | +919.0% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 21 | -97.9% | 0.00% | -100.0% |
Q4 2018 | $14,000 | -78.8% | 983 | -72.8% | 0.00% | -80.0% |
Q3 2018 | $66,000 | -99.9% | 3,608 | -28.1% | 0.01% | -28.6% |
Q2 2018 | $84,706,000 | +445721.1% | 5,021 | +426.9% | 0.01% | +250.0% |
Q1 2018 | $19,000 | +533.3% | 953 | +417.9% | 0.00% | – |
Q3 2017 | $3,000 | -57.1% | 184 | -64.2% | 0.00% | -100.0% |
Q2 2017 | $7,000 | -22.2% | 514 | -25.0% | 0.00% | 0.0% |
Q1 2017 | $9,000 | -10.0% | 685 | -33.8% | 0.00% | 0.0% |
Q4 2016 | $10,000 | -93.5% | 1,035 | -94.2% | 0.00% | -93.3% |
Q2 2016 | $155,000 | – | 17,955 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |